Browsing publications by Dr Joyce Nutt

Newcastle AuthorsTitleYearFull text
Dr Joyce Nutt
Kieran O'Toole
Dr Fiona Black
Mike Cole
Professor Ruth Plummer
et al.
Expression of methylthioadenosine phosphorylase (MTAP) in malignant pleural mesothelioma (MPM) and its implication for pemetrexed-based chemotherapy2010
Dr Joyce Nutt
Kieran O'Toole
Dr Fiona Black
Amy Quinn
Professor Alan Calvert
et al.
The role of folate receptor alpha (FR alpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy2010
Dr Joyce Nutt
Kieran O'Toole
Dr Fiona Black
Professor Ruth Plummer
Professor Alan Calvert
et al.
Expression of folate receptor alpha (FRa) in malignant pleural mesothelioma patients by immunohistochemistry: a clinico-pathological analysis2009
Dr Joyce Nutt
Kieran O'Toole
Professor John Lunec
Growth inhibition by tyrosine kinase inhibitors in mesothelioma cell lines2009
Dr Joyce Nutt
Professor John Lunec
The wide variation in response of mesothelioma cell lines to pemetrexed and lack of relationship to presence of folate receptor alpha (Fra)2009
Dr Joyce Nutt
Kilian Mellon
Professor John Lunec
hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumours2007
Dr Joyce Nutt
Henry Lazarowicz
Kilian Mellon
Professor John Lunec
Gefitinib ('Iressa', ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP22004
Garrett Durkan
Dr Joyce Nutt
Colin Marsh
Dr Mary Robinson
Professor David Neal
et al.
Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer2003
Dr Joyce Nutt
Garrett Durkan
Kilian Mellon
Professor John Lunec
Matrix metalloproteinases (MMPs) in bladder cancer: The induction of MMP9 by epidermal growth factor and its detection in urine2003
Garrett Durkan
Dr Joyce Nutt
Professor David Neal
Professor John Lunec
Kilian Mellon
et al.
Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder2001
12